SIRT3 and chronic kidney disease: Considering that Sirt3 contributes to the alleviation of VC and may be regulated by similar upstream signaling pathways as Sirt1 [20,21], we hypothesize that IMD inhibits mitochondrial oxidative stress by regulating Sirt3 and ultimately attenuates VC in CKD.